Your browser doesn't support javascript.
loading
Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia - implications for the European LeukemiaNet risk classification.
Eckardt, Jan-Niklas; Bill, Marius; Rausch, Christian; Metzeler, Klaus; Spiekermann, Karsten; Stasik, Sebastian; Sauer, Tim; Scholl, Sebastian; Hochhaus, Andreas; Crysandt, Martina; Brümmendorf, Tim H; Krug, Utz; Wörmann, Bernhard; Hiddemann, Wolfgang; Görlich, Dennis; Sauerland, Cristina; Steffen, Björn; Einsele, Hermann; Neubauer, Andreas; Burchert, Andreas; Schäfer-Eckart, Kerstin; Berdel, Wolfgang E; Schliemann, Christoph; Krause, Stefan W; Hänel, Mathias; Hanoun, Maher; Kaufmann, Martin; Fransecky, Lars; Braess, Jan; Ruhnke, Leo; Schetelig, Johannes; Middeke, Jan Moritz; Serve, Hubert; Baldus, Claudia D; Platzbecker, Uwe; Müller-Tidow, Carsten; Bornhäuser, Martin; Herold, Tobias; Thiede, Christian; Röllig, Christoph.
Afiliação
  • Eckardt JN; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
  • Bill M; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
  • Rausch C; Mildred Scheel Early Career Center, Medical Clinic and Policlinic I, University Hospital of the Technical University Dresden, Dresden, Germany.
  • Metzeler K; National Center for Tumor Diseases Dresden (NCT/UCC), Medical Faculty and University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
  • Spiekermann K; German Cancer Consortium (DKTK), Dresden, Germany.
  • Stasik S; Laboratory for Leukemia Diagnostics, Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany.
  • Sauer T; Medical Clinic and Policlinic I Hematology and Cell Therapy, University Hospital, Leipzig, Germany.
  • Scholl S; Laboratory for Leukemia Diagnostics, Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany.
  • Hochhaus A; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
  • Crysandt M; German Cancer Research Center (DKFZ) and Medical Clinic V, University Hospital Heidelberg, Heidelberg, Germany.
  • Brümmendorf TH; Klinik für Innere Medizin II, Jena University Hospital, Jena, Germany.
  • Krug U; Klinik für Innere Medizin II, Jena University Hospital, Jena, Germany.
  • Wörmann B; Department of Hematology, Oncology, Hemostaseology, and Cell Therapy, University Hospital RWTH Aachen, Aachen, Germany.
  • Hiddemann W; Department of Hematology, Oncology, Hemostaseology, and Cell Therapy, University Hospital RWTH Aachen, Aachen, Germany.
  • Görlich D; Department of Medicine III, Hospital Leverkusen, Leverkusen, Germany.
  • Sauerland C; Department of Hematology, Oncology and Tumor Immunology, Charité, Berlin, Germany.
  • Steffen B; Laboratory for Leukemia Diagnostics, Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany.
  • Einsele H; Institute for Biostatistics and Clinical Research, University Muenster, Muenster, Germany.
  • Neubauer A; Institute for Biostatistics and Clinical Research, University Muenster, Muenster, Germany.
  • Burchert A; Medical Clinic II, University Hospital Frankfurt, Frankfurt (Main), Germany.
  • Schäfer-Eckart K; Medical Clinic and Policlinic II, University Hospital Würzburg, Würzburg, Germany.
  • Berdel WE; Department of Hematology, Oncology and Immunology, Philipps-University-Marburg, Marburg, Germany.
  • Schliemann C; Department of Hematology, Oncology and Immunology, Philipps-University-Marburg, Marburg, Germany.
  • Krause SW; Department of Internal Medicine V, Paracelsus Medizinische Privatuniversität and University Hospital Nuremberg, Nuremberg, Germany.
  • Hänel M; Department of Medicine A, University Hospital Münster, Münster, Germany.
  • Hanoun M; Department of Medicine A, University Hospital Münster, Münster, Germany.
  • Kaufmann M; University Hospital Erlangen, Erlangen,, Germany.
  • Fransecky L; Medical Clinic III, Chemnitz Hospital AG, Chemnitz, Germany.
  • Braess J; Department of Hematology, University Hospital Essen, Essen, Germany.
  • Ruhnke L; Department of Hematology, Oncology and Palliative Care, Robert-Bosch-Hospital, Stuttgart, Germany.
  • Schetelig J; Department of Internal Medicine, University Hospital Kiel, Kiel, Germany.
  • Middeke JM; Hospital Barmherzige Brueder Regensburg, Regensburg, Germany.
  • Serve H; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
  • Baldus CD; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
  • Platzbecker U; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
  • Müller-Tidow C; Medical Clinic II, University Hospital Frankfurt, Frankfurt (Main), Germany.
  • Bornhäuser M; Department of Internal Medicine, University Hospital Kiel, Kiel, Germany.
  • Herold T; Medical Clinic and Policlinic I Hematology and Cell Therapy, University Hospital, Leipzig, Germany.
  • Thiede C; German Cancer Research Center (DKFZ) and Medical Clinic V, University Hospital Heidelberg, Heidelberg, Germany.
  • Röllig C; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
Leukemia ; 37(11): 2282-2285, 2023 11.
Article em En | MEDLINE | ID: mdl-37679502

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article